{
  "paper_id": "20a7363b3ad53472952cc80c03489ff56b7178bc",
  "metadata": {
    "title": "Safety of Tdap vaccine in pregnant women: an observational study",
    "coda_data_split": "dev",
    "coda_paper_id": 1894,
    "coda_has_expert_labels": false,
    "subset": "noncomm_use_subset"
  },
  "abstract": [
    {
      "original_text": "Objectives: Actively recruit and intensively follow pregnant women receiving a dose of acellular pertussis vaccine for 4 weeks after vaccination. Design and settings: A prospective observational study conducted in 2 New Zealand regions. Participants: Women in their 28th-38th week of pregnancy, recruited from primary care and antenatal clinics at the time of Tdap administration. Telephone interviews were conducted at 48 h and 4 weeks postvaccination.",
      "sentences": [
        [
          {
            "segment_text": "Objectives : Actively recruit and intensively follow pregnant women receiving a dose of acellular pertussis vaccine for 4 weeks after vaccination .",
            "crowd_label": "purpose"
          }
        ],
        [
          {
            "segment_text": "Design and settings : A prospective observational study conducted in 2 New Zealand regions .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "Participants : Women in their 28th-38th week of pregnancy ,",
            "crowd_label": "method"
          },
          {
            "segment_text": "recruited from primary care and antenatal clinics at the time of Tdap administration .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "Telephone interviews were conducted at 48 h and 4 weeks postvaccination .",
            "crowd_label": "method"
          }
        ]
      ]
    },
    {
      "original_text": "Main outcomes measures: Outcomes were injection site reactions, systemic symptoms and serious adverse events (SAEs). Where available, data have been classified and reported according to Brighton Collaboration definitions.",
      "sentences": [
        [
          {
            "segment_text": "Main outcomes measures : Outcomes were injection site reactions ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "systemic symptoms and serious adverse events ( SAEs ) .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Where available , data have been classified and reported according to Brighton Collaboration definitions .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "2",
    "sentence_num": "6",
    "segment_num": "8",
    "token_num": "108"
  }
}